cached image

Geoffrey M. Cooper - Publications

Affiliations: 
Biology Boston University, Boston, MA, United States 
Area:
Cancer Research
Website:
http://www.bu.edu/biology/people/faculty/cooper/

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Adams KW, Kletsov S, Lamm RJ, Elman JS, Mullenbrock S, Cooper GM. Role for Egr1 in the Transcriptional Program Associated with Neuronal Differentiation of PC12 Cells. Plos One. 12: e0170076. PMID 28076410 DOI: 10.1371/Journal.Pone.0170076  0.798
2012 Nayak G, Cooper GM. p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling. Cell Death & Disease. 3: e400. PMID 23059819 DOI: 10.1038/Cddis.2012.138  0.447
2011 Mullenbrock S, Shah J, Cooper GM. Global expression analysis identified a preferentially nerve growth factor-induced transcriptional program regulated by sustained mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) and AP-1 protein activation during PC12 cell differentiation. The Journal of Biological Chemistry. 286: 45131-45. PMID 22065583 DOI: 10.1074/Jbc.M111.274076  0.793
2011 Tullai JW, Graham JR, Cooper GM. A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells. Cell Cycle (Georgetown, Tex.). 10: 3072-7. PMID 21900749 DOI: 10.4161/Cc.10.18.17321  0.7
2011 Terragni J, Nayak G, Banerjee S, Medrano JL, Graham JR, Brennan JF, Sepulveda S, Cooper GM. The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling. The Journal of Biological Chemistry. 286: 36215-27. PMID 21873430 DOI: 10.1074/Jbc.M111.246116  0.822
2011 Tullai JW, Tacheva S, Owens LJ, Graham JR, Cooper GM. AP-1 is a component of the transcriptional network regulated by GSK-3 in quiescent cells. Plos One. 6: e20150. PMID 21647439 DOI: 10.1371/Journal.Pone.0020150  0.675
2010 Graham JR, Hendershott MC, Terragni J, Cooper GM. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Molecular and Cellular Biology. 30: 5295-305. PMID 20855526 DOI: 10.1128/Mcb.00303-10  0.809
2010 Saxena UH, Owens L, Graham JR, Cooper GM, Hansen U. Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs. The Journal of Biological Chemistry. 285: 31139-47. PMID 20682773 DOI: 10.1074/Jbc.M109.078808  0.616
2010 Graham JR, Tullai JW, Cooper GM. GSK-3 represses growth factor-inducible genes by inhibiting NF-κB in quiescent cells Journal of Biological Chemistry. 285: 4472-4480. PMID 20018891 DOI: 10.1074/Jbc.M109.053785  0.672
2009 Saxena UH, Powell CM, Fecko JK, Cacioppo R, Chou HS, Cooper GM, Hansen U. Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression. Molecular and Cellular Biology. 29: 2335-45. PMID 19237534 DOI: 10.1128/Mcb.00687-08  0.399
2008 Terragni J, Graham JR, Adams KW, Schaffer ME, Tullai JW, Cooper GM. Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors. Bmc Cell Biology. 9: 6. PMID 18226221 DOI: 10.1186/1471-2121-9-6  0.811
2007 Tullai JW, Schaffer ME, Mullenbrock S, Sholder G, Kasif S, Cooper GM. Immediate-early and delayed primary response genes are distinct in function and genomic architecture. The Journal of Biological Chemistry. 282: 23981-95. PMID 17575275 DOI: 10.1074/Jbc.M702044200  0.764
2007 Tullai JW, Chen J, Schaffer ME, Kamenetsky E, Kasif S, Cooper GM. Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells. The Journal of Biological Chemistry. 282: 9482-91. PMID 17277356 DOI: 10.1074/Jbc.M700067200  0.774
2007 Adams KW, Cooper GM. Rapid turnover of mcl-1 couples translation to cell survival and apoptosis. The Journal of Biological Chemistry. 282: 6192-200. PMID 17200126 DOI: 10.1074/Jbc.M610643200  0.331
2005 Gross VS, Hess M, Cooper GM. Mouse embryonic stem cells and preimplantation embryos require signaling through the phosphatidylinositol 3-kinase pathway to suppress apoptosis. Molecular Reproduction and Development. 70: 324-32. PMID 15625701 DOI: 10.1002/Mrd.20212  0.432
2004 Tullai JW, Schaffer ME, Mullenbrock S, Kasif S, Cooper GM. Identification of transcription factor binding sites upstream of human genes regulated by the phosphatidylinositol 3-kinase and MEK/ERK signaling pathways. The Journal of Biological Chemistry. 279: 20167-77. PMID 14769801 DOI: 10.1074/Jbc.M309260200  0.786
2004 Zilz A, Cooper GM. A binding site for germ cell nuclear factor within c-mos regulatory sequences. Molecular Reproduction and Development. 67: 55-64. PMID 14648874 DOI: 10.1002/Mrd.20006  0.384
2003 Pagon Z, Volker J, Cooper GM, Hansen U. Mammalian transcription factor LSF is a target of ERK signaling. Journal of Cellular Biochemistry. 89: 733-46. PMID 12858339 DOI: 10.1002/Jcb.10549  0.483
2002 Hartley D, Cooper GM. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. Journal of Cellular Biochemistry. 85: 304-14. PMID 11948686 DOI: 10.1002/Jcb.10135  0.39
2002 Pap M, Cooper GM. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway. Molecular and Cellular Biology. 22: 578-86. PMID 11756553 DOI: 10.1128/Mcb.22.2.578-586.2002  0.44
2000 Hartley DA, Cooper GM. Direct binding and activation of STAT transcription factors by the herpesvirus saimiri protein tip. The Journal of Biological Chemistry. 275: 16925-32. PMID 10747948 DOI: 10.1074/Jbc.M000709200  0.48
1999 Lin H, Jurk M, Gulick T, Cooper GM. Identification of COUP-TF as a transcriptional repressor of the c-mos proto-oncogene. Journal of Biological Chemistry. 274: 36796-36800. PMID 10593989 DOI: 10.1074/Jbc.274.51.36796  0.377
1999 Erhardt P, Schremser EJ, Cooper GM. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway Molecular and Cellular Biology. 19: 5308-5315. PMID 10409722 DOI: 10.1128/Mcb.19.8.5308  0.42
1998 Pap M, Cooper GM. Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway Journal of Biological Chemistry. 273: 19929-19932. PMID 9685326 DOI: 10.1074/Jbc.273.32.19929  0.431
1998 Boglári G, Erhardt P, Cooper GM, Szeberényi J. Intact Ras function is required for sustained activation and nuclear translocation of extracellular signal-regulated kinases in nerve growth factor-stimulated PC12 cells European Journal of Cell Biology. 75: 54-58. PMID 9523155 DOI: 10.1016/S0171-9335(98)80046-0  0.459
1997 Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Molecular and Cellular Biology. 17: 3850-3857. PMID 9199319 DOI: 10.1128/Mcb.17.7.3850  0.443
1997 Erhardt P, Tomaselli KJ, Cooper GM. Identification of the MDM2 oncoprotein as a substrate for CPP32-like apoptotic proteases Journal of Biological Chemistry. 272: 15049-15052. PMID 9182520 DOI: 10.1074/Jbc.272.24.15049  0.322
1997 Lopes UG, Erhardt P, Yao R, Cooper GM. p53-dependent induction of apoptosis by proteasome inhibitors Journal of Biological Chemistry. 272: 12893-12896. PMID 9148891 DOI: 10.1074/Jbc.272.20.12893  0.368
1997 Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (New York, N.Y.). 275: 661-5. PMID 9005851 DOI: 10.1126/Science.275.5300.661  0.4
1997 Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U, Cooper GM. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Molecular and Cellular Biology. 17: 732-741. PMID 9001227 DOI: 10.1128/Mcb.17.2.732  0.44
1996 Erhardt P, Cooper GM. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-x(L) Journal of Biological Chemistry. 271: 17601-17604. PMID 8663611 DOI: 10.1074/Jbc.271.30.17601  0.438
1995 Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor Science. 267: 2003-2006. PMID 7701324 DOI: 10.1126/Science.7701324  0.45
1995 Erhardt P, Troppmair J, Rapp UR, Cooper GM. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells Molecular and Cellular Biology. 15: 5524-5530. PMID 7565704 DOI: 10.1128/Mcb.15.10.5524  0.428
1995 Xu W, Cooper GM. Identification of a candidate c-mos repressor that restricts transcription of germ cell-specific genes. Molecular and Cellular Biology. 15: 5369-5375. PMID 7565687 DOI: 10.1128/Mcb.15.10.5369  0.454
1994 Yamauchi N, Kiessling AA, Cooper GM. The Ras/Raf signaling pathway is required for progression of mouse embryos through the two-cell stage. Molecular and Cellular Biology. 14: 6655-6662. PMID 7935384 DOI: 10.1128/Mcb.14.10.6655  0.345
1994 Pal SK, Torry D, Serta R, Crowell RC, Seibel MM, Cooper GM, Kiessling AA. Expression and potential function of the c-mos proto-oncogene in human eggs**Supported by the Faulkner Institute For Reproductive Medicine, Faulkner Centre for Reproductive Medicine, Boston, Massachusetts, in part by grant RO1 HD26594, T32 CA09031, and F32 GM13632, National Institutes of Health, Bethesda, Maryland and an Investigator Award from the Claudia Adams Barr Program for Cancer Research.††Presented in part at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 31 to April 3, 1993. Fertility and Sterility. 61: 496-503. DOI: 10.1016/S0015-0282(16)56582-0  0.342
1993 Pal SK, Crowell R, Kiessling AA, Cooper GM. Expression of proto-oncogenes in mouse eggs and preimplantation embryos. Molecular Reproduction and Development. 35: 8-15. PMID 8507485 DOI: 10.1002/Mrd.1080350103  0.393
1993 Schweighoffer F, Cai H, Chevallier-Multon MC, Fath I, Cooper G, Tocque B. The Saccharomyces cerevisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-Ras Asn-17. Molecular and Cellular Biology. 13: 39-43. PMID 8380225 DOI: 10.1128/Mcb.13.1.39  0.355
1993 Cai H, Erhardt P, Troppmair J, Diaz-Meco MT, Sithanandam G, Rapp UR, Muscat J, Cooper GM. Hydrolysis of phosphatidylcholine couples ras to activation of raf protein kinase during mitogenic signal transduction Molecular and Cellular Biology. 13: 7645-7651. PMID 8246981 DOI: 10.1128/Mcb.13.12.7645  0.419
1993 Fanger GR, Erhardt P, Cooper GM, Maue RA. ras-Independent induction of rat brain type II sodium channel expression in nerve growth factor-treated PC12 cells Journal of Neurochemistry. 61: 1977-1980. PMID 8229007 DOI: 10.1111/J.1471-4159.1993.Tb09844.X  0.371
1992 Zinkel SS, Pal SK, Szeberényi J, Cooper GM. Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells. Molecular and Cellular Biology. 12: 2029-2036. PMID 1533271 DOI: 10.1128/Mcb.12.5.2029  0.393
1992 Cai H, Erhardt P, Szeberényi J, Diaz-Meco MT, Johansen T, Muscat J, Cooper GM. Hydrolysis of phosphatidylcholine is stimulated by ras proteins during mitogenic signal transduction Molecular and Cellular Biology. 12: 5329-5335. PMID 1448068 DOI: 10.1128/Mcb.12.12.5329  0.381
1991 Torry DS, Cooper GM. Proto-oncogenes in development and cancer American Journal of Reproductive Immunology. 25: 129-132. PMID 1930640 DOI: 10.1111/J.1600-0897.1991.Tb01080.X  0.432
1991 Pal SK, Zinkel SS, Kiessling AA, Cooper GM. c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site. Molecular and Cellular Biology. 11: 5190-5196. PMID 1833632 DOI: 10.1128/Mcb.11.10.5190  0.404
1991 O'Keefe SJ, Kiessling AA, Cooper GM. The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs. Proceedings of the National Academy of Sciences of the United States of America. 88: 7869-7872. PMID 1652768 DOI: 10.1073/Pnas.88.17.7869  0.327
1990 Szeberényi J, Cai H, Cooper GM. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Molecular and Cellular Biology. 10: 5324-5332. PMID 2118994 DOI: 10.1128/Mcb.10.10.5324  0.456
1990 Cai H, Szeberényi J, Cooper GM. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Molecular and Cellular Biology. 10: 5314-5323. PMID 2118993 DOI: 10.1128/Mcb.10.10.5314  0.439
1989 Stanton VP, Nichols DW, Laudano AP, Cooper GM. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Molecular and Cellular Biology. 9: 639-647. PMID 2710120 DOI: 10.1128/Mcb.9.2.639  0.379
1989 Wolfes H, Kogawa K, Millette CF, Cooper GM. Specific expression of nuclear proto-oncogenes before entry into meiotic prophase of spermatogenesis. Science (New York, N.Y.). 245: 740-3. PMID 2475907 DOI: 10.1126/Science.2475907  0.39
1988 Feig LA, Cooper GM. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP Molecular and Cellular Biology. 8: 3235-3243. PMID 3145408 DOI: 10.1128/Mcb.8.8.3235  0.416
1987 Takahashi M, Cooper GM. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Molecular and Cellular Biology. 7: 1378-1385. PMID 3037315 DOI: 10.1128/Mcb.7.4.1378  0.482
1987 Feig LA, Corbley M, Pan BT, Roberts TM, Cooper GM. Structure/function analysis of ras using random mutagenesis coupled with functional screening assays Molecular Endocrinology (Baltimore, Md.). 1: 127-136. PMID 2842663 DOI: 10.1210/Mend-1-2-127  0.369
1987 Stanton VP, Cooper GM. Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences. Molecular and Cellular Biology. 7: 1171-1179. DOI: 10.1128/MCB.7.3.1171  0.326
1986 Carney WP, Hamer P, Petit D, Wolfe H, Cooper G, Lefebvre M, Rabin H. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12. Journal of Cellular Biochemistry. 32: 207-14. PMID 3536974 DOI: 10.1002/Jcb.240320307  0.342
1986 Der CJ, Finkel T, Cooper GM. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell. 44: 167-76. PMID 3510078 DOI: 10.1016/0092-8674(86)90495-2  0.544
1986 Der CJ, Pan BT, Cooper GM. rasH mutants deficient in GTP binding. Molecular and Cellular Biology. 6: 3291-4. PMID 3097518 DOI: 10.1128/Mcb.6.9.3291  0.502
1986 Carney WP, Petit D, Hamer P, Der CJ, Finkel T, Cooper GM, Lefebvre M, Mobtaker H, Delellis R, Tischler AS. Monoclonal antibody specific for an activated RAS protein. Proceedings of the National Academy of Sciences of the United States of America. 83: 7485-9. PMID 3094010 DOI: 10.1073/Pnas.83.19.7485  0.532
1986 Feig LA, Pan BT, Roberts TM, Cooper GM. Isolation of ras GTP-binding mutants using an in situ colony-binding assay Proceedings of the National Academy of Sciences of the United States of America. 83: 4607-4611. PMID 3088563 DOI: 10.1073/Pnas.83.13.4607  0.37
1986 Cooper GM, Diamond A. Mechanism of activation of HuBlym-1 gene unresolved (reply) Nature. 321: 438-439. DOI: 10.1038/321438A0  0.416
1986 Cooper GM, Goubin G, Diamond A, Neiman P. Relationship of Blym genes to repeated sequences Nature. 320: 579-580. DOI: 10.1038/320579C0  0.346
1985 Diamond A, Devine JM, Lane MA, Cooper GM. The isolation and characterization of the Blym-1 transforming gene. Basic Life Sciences. 33: 141-52. PMID 4015580 DOI: 10.1007/978-1-4684-4970-9_9  0.357
1985 Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement Cell. 42: 581-588. PMID 2992805 DOI: 10.1016/0092-8674(85)90115-1  0.37
1984 Feig LA, Bast RC, Knapp RC, Cooper GM. Somatic activation of rasK gene in a human ovarian carcinoma Science. 223: 698-701. PMID 6695178 DOI: 10.1126/Science.6695178  0.419
1984 Morton CC, Taub R, Diamond A, Lane MA, Cooper GM, Leder P. Mapping of the human Blym-1 transforming gene activated in Burkitt lymphomas to chromosome 1. Science (New York, N.Y.). 223: 173-5. PMID 6691143 DOI: 10.1126/Science.6691143  0.356
1984 Devine JM, Diamond A, Lane MA, Cooper GM. Characterization of the Blym-1 transforming genes of chicken and human B-cell lymphomas. Journal of Cellular Physiology. Supplement. 3: 193-8. PMID 6611341 DOI: 10.1002/Jcp.1041210422  0.382
1984 Finkel T, Der CJ, Cooper GM. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell. 37: 151-8. PMID 6609772 DOI: 10.1016/0092-8674(84)90310-6  0.559
1984 Cooper GM. Structural and functional analysis of ras and Blym oncogenes Current Topics in Microbiology and Immunology. 113: 34-36. PMID 6478867 DOI: 10.1007/978-3-642-69860-6_7  0.393
1984 Cooper GM. The 1984 Walter Hubert lecture. Activation of transforming genes in neoplasms. British Journal of Cancer. 50: 137-142. PMID 6380552 DOI: 10.1038/Bjc.1984.155  0.443
1984 Cooper GM, Lane M. Cellular transforming genes and oncogenesis. Biochimica Et Biophysica Acta. 738: 9-20. PMID 6331501 DOI: 10.1016/0304-419X(84)90017-9  0.35
1984 Diamond A, Devine JM, Cooper GM. Nucleotide sequence of a human Blym transforming gene activated in a Burkitt's lymphoma. Science (New York, N.Y.). 225: 516-9. PMID 6330897 DOI: 10.1126/Science.6330897  0.414
1984 Lane MA, Sainten A, Doherty KM, Cooper GM. Isolation and characterization of a stage-specific transforming gene, Tlym-I, from T-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 81: 2227-31. PMID 6326114 DOI: 10.1073/Pnas.81.7.2227  0.435
1983 Der CJ, Cooper GM. Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell. 32: 201-8. PMID 6825168 DOI: 10.1016/0092-8674(83)90510-X  0.57
1983 Cooper GM. Transforming Genes of Neoplasms Progress in Nucleic Acid Research and Molecular Biology. 29: 273-277. PMID 6665173 DOI: 10.1016/S0079-6603(08)60459-6  0.417
1983 Goubin G, Goldman DS, Luce J, Neiman PE, Cooper GM. Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNA. Nature. 302: 114-9. PMID 6600817 DOI: 10.1038/302114A0  0.401
1983 Diamond A, Cooper GM, Ritz J, Lane MA. Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas. Nature. 305: 112-6. PMID 6310408 DOI: 10.1038/305112A0  0.425
1982 Lane M, Neary D, Cooper GM. Activation of a cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature. 300: 659-661. PMID 6292739 DOI: 10.1038/300659A0  0.4
1982 Cooper GM. Cellular transforming genes Science. 217: 801-806. PMID 6285471 DOI: 10.1126/Science.6285471  0.423
1982 Der CJ, Krontiris TG, Cooper GM. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proceedings of the National Academy of Sciences of the United States of America. 79: 3637-40. PMID 6285355 DOI: 10.1073/Pnas.79.11.3637  0.569
1982 Lane M, Sainten A, Cooper GM. Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms Cell. 28: 873-880. PMID 6284377 DOI: 10.1016/0092-8674(82)90066-6  0.405
1982 Cooper GM. Transforming genes of chicken bursal lymphomas Journal of Cellular Physiology. 110: 209-212. PMID 6279675 DOI: 10.1002/Jcp.1041130428  0.458
1981 Krontiris TG, Cooper GM. Transforming activity of human tumor DNAs Proceedings of the National Academy of Sciences of the United States of America. 78: 1181-1184. PMID 6940134 DOI: 10.1073/Pnas.78.2.1181  0.36
1981 Lane M, Sainten A, Cooper GM. Activation of related transforming genes in mouse and human mammary carcinomas Proceedings of the National Academy of Sciences of the United States of America. 78: 5185-5189. PMID 6272293 DOI: 10.1073/Pnas.78.8.5185  0.347
1981 Cooper GM, Neiman PE. Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms Nature. 292: 857-858. PMID 6267476 DOI: 10.1038/292857A0  0.439
1981 Shalloway D, Zelenetz AD, Cooper GM. Molecular cloning and characterization of the chicken gene homologous to the transforming gene of rous sarcoma virus Cell. 24: 531-541. PMID 6263499 DOI: 10.1016/0092-8674(81)90344-5  0.386
1981 Cooper GM, Copeland NG, Zelenetz AD, Krontiris T. Transformation of NIH-3T3 mouse cells by avian retroviral DNAs. Cold Spring Harbor Symposia On Quantitative Biology. 1169-76. PMID 6253192 DOI: 10.1101/Sqb.1980.044.01.126  0.351
1980 Cooper GM, Okenquist S, Silverman L. Transforming activity of DNA of chemically transformed and normal cells. Nature. 284: 418-421. PMID 7360280 DOI: 10.1038/284418A0  0.372
1980 Cooper GM, Neiman PE. Transforming genes of neoplasms induced by avian lymphoid leukosis viruses. Nature. 287: 656-659. PMID 6253808 DOI: 10.1038/287656A0  0.43
1980 Jenkins NA, Cooper GM. Integration, expression, and infectivity of exogenously acquired proviruses of Rous-associated virus-O. Journal of Virology. 36: 684-691. DOI: 10.1128/Jvi.36.3.684-691.1980  0.314
1979 Copeland NG, Zelenetz AD, Cooper GM. Transformation of NIH/3T3 mouse cells by DNA of Rous sarcoma virus. Cell. 17: 993-1002. PMID 226269 DOI: 10.1016/0092-8674(79)90338-6  0.317
1978 Neiman PE, McMillin-Helsel C, Cooper GM. Specific restriction of avian sarcoma viruses by a line of transformed lymphoid cells. Virology. 89: 360-371. PMID 213875 DOI: 10.1016/0042-6822(78)90178-2  0.331
1976 Cooper GM, Temin HM. Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells. Journal of Virology. 17: 422-30. PMID 176424  0.482
1975 Cooper GM, Temin HM. Infectious DNA from cells infected with Rous sarcoma virus, reticuloendotheliosis virus or Rous-associated virus-O. Cold Spring Harbor Symposia On Quantitative Biology. 39: 1027-32. PMID 169004  0.471
1975 Schildkraut I, Cooper GM, Greer S. Selective inhibition of the replication of herpes simplex virus by 5-halogenated analogues of deoxycytidine. Molecular Pharmacology. 11: 153-8. PMID 164617  0.416
1974 Cooper GM, Temin HM. Infectious rous sarcoma virus and reticuloendotheliosis virus DNAs. Journal of Virology. 14: 1132-41. PMID 4372391 DOI: 10.1128/Jvi.14.5.1132-1141.1974  0.442
1973 Cooper GM, Greer S. Phosphorylation of 5-halogenated deoxycytidine analogues by deoxycytidine kinase. Molecular Pharmacology. 9: 704-10. PMID 4762632  0.493
1973 Cooper GM, Greer S. The effect of inhibition of cytidine deaminase by tetrahydrouridine on the utilization of deoxycytidine and 5-bromodeoxycytidine for deoxyribonucleic acid synthesis. Molecular Pharmacology. 9: 698-703. PMID 4762631  0.426
1973 Cooper GM. Phosphorylation of 5 bromodeoxycytidine in cells infected with herpes simplex virus Proceedings of the National Academy of Sciences of the United States of America. 70: II. PMID 4359489 DOI: 10.1073/Pnas.70.12.3788  0.339
1972 Cooper GM, Dunning WF, Greer S. Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo. Cancer Research. 32: 390-7. PMID 5058194  0.414
1970 Cooper GM, Greer S. Irreversible inhibition of dehalogenation of 5-iodouracil by 5-diazouracil and reversible inhibition by 5-cyanouracil. Cancer Research. 30: 2937-41. PMID 5494578  0.433
Show low-probability matches.